Skip to content
★ Sign in to follow
CL

Carl Lindgren

Karo Pharma AB
Total declarations
20
Company
1
▲ Purchases (17 ops.)
€328k
▼ Sales (1 ops.)
—

Latest filing published 23 Jan 2019 for Karo Pharma AB.

Filing timeline

BuySale
Carl Lindgren

Insider track record

Disclosed buys
17
Disclosed sells
1
Signal history

Closed purchases

Market purchases
17

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Carl Lindgren: trading record in brief

All filings by Carl Lindgren on record concern Karo Pharma AB. In total, 20 filings cover trades dated from 24 August 2017 to 22 January 2019.

Both buying and selling appear: 17 purchases worth €328k, against 1 sale. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2019 alone, the filings show no purchases and 1 sale.

A typical purchase (the median) is worth €6,521. Of 17 purchases, 9 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 23 January 2019, the filings show an open-market sale in Karo Pharma AB. The latest purchase dates back some time: it was published 2,962 days ago, on 28 September 2018. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Carl Lindgren

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total
  • ▼
    Vice VDExecutivesKaro Pharma AB
    0FI-SE
    140,000 sharesAktieISIN SE0007464888FI:csv-6967532026fdac00445f
  • ▲
    Vice VDExecutivesKaro Pharma AB
    234,468 SEK22FI-SE
    7,491 shares@ SEK 31.300.0% of flowAktieISIN SE0007464888FI:csv-2bfaab2b3d438d2cdb58
    Canonical exit: 27 Dec 2018 (T+90)
  • ●
    Vice VDExecutivesKaro Pharma AB
    60,216 SEK22FI-SE
    2,509 shares@ SEK 24.000.0% of flowFI:csv-ef8a9f9a2774f5122075
  • ▲
    Vice VDExecutivesKaro Pharma AB
    1M SEK34FI-SE
    50,000 shares@ SEK 24.000.0% of flowISIN SE0010663039FI:csv-53c13b46750a6e165ef2
    Canonical exit: 28 Aug 2018 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    9,576 SEK34FI-SE
    20,000 shares@ SEK 0.47880.0% of flowISIN SE0011204809FI:csv-4fb12d43ff6b2f249b28
    Canonical exit: 21 Aug 2018 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    162,250 SEK37FI-SE
    5,000 shares@ SEK 32.450.0% of flowISIN SE0007464888FI:csv-16c8c45a5653ff415cc5
    Canonical exit: 12 Jun 2018 (T+90)
  • ●
    Vice VDExecutivesKaro Pharma AB
    792,657 SEK24FI-SE
    27,333 shares@ SEK 29.0019.4% of flowISIN SE0010663039FI:csv-bf559a7109dfc743c19a
  • ▲
    Vice VDExecutivesKaro Pharma AB
    5,985 SEK40FI-SE
    4,500 shares@ SEK 1.330.0% of flowISIN SE0010663021FI:csv-e82ca14427ff5c9c20ce
    Canonical exit: 22 Mar 2018 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    5,661 SEK40FI-SE
    167 shares@ SEK 33.900.0% of flowISIN SE0007464888FI:csv-ac44462d85a7e01afa69
    Canonical exit: 21 Mar 2018 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    46,500 SEK40FI-SE
    30,000 shares@ SEK 1.550.0% of flowISIN SE0010663021FI:csv-9f8d83e026d6b0a2317b
    Canonical exit: 20 Mar 2018 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    847,500 SEK22FI-SE
    25,000 shares@ SEK 33.900.0% of flowISIN SE0007464888FI:csv-9b4009608eec4edd0d1e
    Canonical exit: 7 Feb 2018 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    113,700 SEK34FI-SE
    3,000 shares@ SEK 37.900.0% of flowISIN SE0007464888FI:csv-bee3141d5abb03a67bb9
    Canonical exit: 3 Dec 2017 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    189,500 SEK34FI-SE
    5,000 shares@ SEK 37.900.0% of flowISIN SE0007464888FI:csv-2e5b377bf867903dddf5
    Canonical exit: 4 Dec 2017 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    189,000 SEK34FI-SE
    5,000 shares@ SEK 37.800.0% of flowISIN SE0007464888FI:csv-8aefee83d1e2166be994
    Canonical exit: 4 Dec 2017 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    36,500 SEK22FI-SE
    1,000 shares@ SEK 36.500.0% of flowISIN SE0007464888FI:csv-9e5c2cd8e42e19b338ea
    Canonical exit: 27 Nov 2017 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    37,000 SEK22FI-SE
    1,000 shares@ SEK 37.000.0% of flowISIN SE0007464888FI:csv-524d63e6d9c0360832c0
    Canonical exit: 27 Nov 2017 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    19,950 SEK22FI-SE
    500 shares@ SEK 39.900.0% of flowISIN SE0007464888FI:csv-d2f3d8762f97cd59388c
    Canonical exit: 23 Nov 2017 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    20,500 SEK22FI-SE
    500 shares@ SEK 41.000.0% of flowISIN SE0007464888FI:csv-9449db415655154dcaa1
    Canonical exit: 22 Nov 2017 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    78,200 SEK22FI-SE
    2,000 shares@ SEK 39.100.0% of flowISIN SE0007464888FI:csv-2630930fec06b726c266
    Canonical exit: 22 Nov 2017 (T+90)
  • ▲
    Vice VDExecutivesKaro Pharma AB
    62,100 SEK22FI-SE
    1,500 shares@ SEK 41.400.0% of flowISIN SE0007464888FI:csv-d160a11cd488ff362587
    Canonical exit: 22 Nov 2017 (T+90)

20 of 20 declarations